Genmab A/SGMABNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P21
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-18.78%
202483.82%
2023-20.84%
202284.51%
2021-38.08%
2020112.21%
201943.33%
201832.60%
2017-8.59%
201651.15%